AlphaVax Company
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Durham, North Carolina, United States
Founded Date:
1997
Employees Number:
51-100
Funding Status:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Register and Claim Ownership